- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05784831
Development and Feasibility Test of an Ecological Momentary Intervention (EMI) - ReApp, to Increase Reappraisal.
Development and Feasibility Test of an Ecological Momentary Intervention (EMI) - ReApp, to Promote and Improve Stress Resilience, Specifically to Increase Reappraisal.
The aim of the current project is to develop and test Ecological Momentary Interventions (EMIs) to promote and improve stress resilience, specifically, an EMI to increase positive reappraisal.
EMIs are mostly smartphone-based applications that deliver interventions to people as they go about in their daily lives. The EMI tested here is based on theoretical and empirical findings and consists of several items and repeated training using various individual scenarios from participants' life that will be presented to participants via an app on their smartphones.
This study tests the efficacy of the EMI on a change in (i) reappraisal and (ii) indices of perceived stress. One hundred twenty healthy student participants, aged 18-29 will be invited to the study. Participants will be screened and those who score below 13 points of reappraisal skills in a Cognitive Emotion Regulation Questionnaire, will be included in the study. This is necessary in order to avoid a ceiling effect on reappraisal skills, which may be high in students.
Then, the participants will be randomly assigned to experimental (reappraisal EMI in regular and burst design) and control conditions (control EMA) and fill in questionnaires. The reappraisal EMI groups will be taught reappraisal skills and will be asked to apply them to personal situations repeatedly. The control EMA group will have the same app consisting of Ecological Momentary Assessment only. The training will last 21 consecutive days and the app will send (i) 5 prompts per day to ask about the current mood of the user in control and both experimental groups and (ii) at least two prompts per day resulting in a total of min. 42 reappraisal training sessions in the regular experimental group or 28 reappraisal training sessions in the burst experimental group. What is more, every participant has the possibility to trigger the EMA or EMI anytime they wish to. After using the app, participants will fill in some questionnaires again. The whole study will be conducted remotely (Video calls and app use) to avoid unnecessary COVID-related risks for participants.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Zurich, Switzerland, 8032
- Psychiatric University Hospital Zurich
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- being a student
- having sufficient knowledge of the German language
- being a smartphone user
- low results in a CERQ questionnaire (less than 13 points in the Positive Reappraisal subscale).
Exclusion Criteria:
(1) having a current mental illness reported in the screening process.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Regular Intervention Group
Group using the app delivering reappraisal training for 21 consecutive days.
|
The EMI developed and tested here is based on theoretical and empirical findings and consists of several items and repeated training using various individual scenarios from participants' life that will be presented to participants via an app on their smartphones.
Other Names:
|
Experimental: Burst Intervention Group
Group using the app delivering reappraisal training for 7 consecutive days, then having 7 days break and again using the app 7 consecutive days.
|
The EMI developed and tested here is based on theoretical and empirical findings and consists of several items and repeated training using various individual scenarios from participants' life that will be presented to participants via an app on their smartphones.
Other Names:
|
Active Comparator: Active Control Group
Group using the ecological momentary assessment app for 21 consecutive days.
|
The EMA tested here collects data on participants' mood and behavior.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perceived Stress Scale (PSS)
Time Frame: 21 days
|
Self-reported level of stress, scale range [0-40], higher score = worse outcome
|
21 days
|
Beck Depression Inventory II (BDI-II)
Time Frame: 21 days
|
Self-reported depressive symptoms, scale range [0-63], higher score = worse outcome
|
21 days
|
Cognitive Emotion Regulation Questionnaire (CERQ)
Time Frame: 21 days
|
Self-reported reappraisal skills, scale range [5-20], higher score = better outcome
|
21 days
|
State-Trait Anxiety Inventory (STAI)
Time Frame: 21 days
|
Self-reported anxiety symptoms, scale range [20-80], higher score = worse outcome
|
21 days
|
Emotion Regulation Questionnaire (ERQ)
Time Frame: 21 days
|
Self-reported reappraisal use, scale range [6-42], higher score = better outcome
|
21 days
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Birgit Kleim, PhD, University of Zurich
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- UZH_ReApp
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
University of PadovaRecruitingStress | Stress Disorder | Work Related StressItaly
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...Enrolling by invitationStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
Duquesne UniversityUniversity of California, San Diego; West Penn Allegheny Health System; El Centro... and other collaboratorsTerminated
-
University of Sao PauloCompleted
-
Dana-Farber Cancer InstituteEnrolling by invitationStress | Post Traumatic Stress Disorder | Work Related StressUnited States
-
Royal Cornwall Hospitals TrustEnrolling by invitationStress | Stress, Psychological | Stress, JobUnited Kingdom
-
Syracuse VA Medical CenterUS Department of Veterans AffairsCompletedEmotional Stress | Psychological Stress | Life StressUnited States
-
Northumbria UniversityVolac International LtdRecruitingStress | Mood | Physiological StressUnited Kingdom
-
Taichung Veterans General HospitalUnknown
Clinical Trials on Reappraisal training
-
Icahn School of Medicine at Mount SinaiCompletedBorderline Personality Disorders | Avoidant Personality DisordersUnited States
-
Ludwig-Maximilians - University of MunichGerman Research Foundation; RWTH Aachen University; University of AmsterdamCompletedMajor Depressive DisorderGermany
-
Virginia Commonwealth UniversityMind & Life FoundationCompleted
-
Karolinska InstitutetCompletedInappropriate Anger ExpressionSweden
-
Virginia Commonwealth UniversityTerminatedBurnout | Sleep | CaregiversUnited States
-
Boston University Charles River CampusNational Institute of Mental Health (NIMH)CompletedSelf Injurious Behavior Without Suicidal IntentUnited States
-
Ohio UniversityRecruitingGeneralized Anxiety Disorder | Emotional DisorderUnited States
-
University of Warsaw, PolandDuke UniversityRecruiting
-
University of DenverWake Forest UniversityRecruiting